HIGHLIGHTS
- who: Alessandro Maloberti and colleagues from the Cardiology, Cardio Center, ASST GOM Niguarda, Piazza Ospedale Maggiore, Milan, Italy School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy have published the research: Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study, in the Journal: Life 2022, 1322 of 27/07/2022
- what: The aim of the pilot study was to further investigate the role of on endothelial function in patients affected by advanced HF. LEVO group (reference) OMT group -0.324 -8 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.